Related Experiment Videos
A mouse model for heparin-induced thrombocytopenia
Seminars in Hematology
|February 4, 1999
Summary
A new mouse model mimics heparin-induced thrombocytopenia (HIT) by developing antibodies against heparin-platelet factor 4 (H-PF4) complexes. This model shows reduced platelet counts upon heparin exposure, aiding HIT research.
Area of Science:
- Immunology
- Hematology
- Pharmacology
Background:
- Heparin-induced thrombocytopenia (HIT) is an immune reaction to heparin-platelet factor 4 (H-PF4) complexes.
- HIT affects 1-3% of patients on heparin, mediated by antibodies recognizing H-PF4 on platelets and endothelium.
Purpose of the Study:
- To develop an animal model for studying the in vivo pathogenic role of anti-H-PF4 antibodies in HIT.
- To investigate the immunoregulation and potential therapies for HIT.
Main Methods:
- Naive mice were immunized with IgG anti-H-PF4 antibodies from HIT patients.
- Developed anti-idiotypic and subsequently anti-anti-idiotypic antibodies mimicking human HIT antibodies.
- Administered heparin and low-molecular-weight heparin (LMWH) to immunized mice.
Main Results:
- Immunized mice developed functional anti-anti-idiotypic antibodies resembling human HIT antibodies.
- Heparin administration to these mice significantly reduced platelet counts but did not cause thrombosis.
- LMWH did not induce thrombocytopenia in the immunized mice, consistent with clinical observations.
Conclusions:
- The developed mouse model supports the pathogenic role of anti-H-PF4 antibodies in HIT.
- This model is valuable for studying HIT immunoregulation and evaluating therapeutic strategies.